392 related articles for article (PubMed ID: 1665407)
21. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
22. Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients.
New JP; Marshall SM; Bilous RW
Diabetologia; 1998 Feb; 41(2):206-11. PubMed ID: 9498655
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
[TBL] [Abstract][Full Text] [Related]
24. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension.
Pedersen EB; Mogensen CE
Scand J Clin Lab Invest; 1976 May; 36(3):231-7. PubMed ID: 945907
[TBL] [Abstract][Full Text] [Related]
25. Renal protective effect of enalapril in diabetic nephropathy.
Björck S; Mulec H; Johnsen SA; Nordén G; Aurell M
BMJ; 1992 Feb; 304(6823):339-43. PubMed ID: 1540729
[TBL] [Abstract][Full Text] [Related]
26. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
Barnett AH
Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
[TBL] [Abstract][Full Text] [Related]
27. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients.
Pedersen MM; Schmitz A; Pedersen EB; Danielsen H; Christiansen JS
Diabet Med; 1988 Sep; 5(6):562-9. PubMed ID: 2850132
[TBL] [Abstract][Full Text] [Related]
29. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
Hommel E
J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
[TBL] [Abstract][Full Text] [Related]
30. Prevention of loss of renal function over time in patients with diabetic nephropathy.
Barnett A
Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
[TBL] [Abstract][Full Text] [Related]
31. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes.
Marre M; Hallab M; Billiard A; Le Jeune JJ; Bled F; Girault A; Fressinaud P
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S165-8. PubMed ID: 1725033
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition.
Chuahirun T; Wesson DE
Am J Kidney Dis; 2002 Feb; 39(2):376-82. PubMed ID: 11840380
[TBL] [Abstract][Full Text] [Related]
33. [Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy].
Hallab M; Billiard A; Lejeune JJ; Bled F; Girault A; Fressinaud P; Marre M
Arch Mal Coeur Vaiss; 1991 Mar; 84(3):383-6. PubMed ID: 1828659
[TBL] [Abstract][Full Text] [Related]
34. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
Parving HH; Andersen AR; Smidt UM; Svendsen PA
Lancet; 1983 May; 1(8335):1175-9. PubMed ID: 6133986
[TBL] [Abstract][Full Text] [Related]
35. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.
Hollenberg NK; Price DA; Fisher ND; Lansang MC; Perkins B; Gordon MS; Williams GH; Laffel LM
Kidney Int; 2003 Jan; 63(1):172-8. PubMed ID: 12472780
[TBL] [Abstract][Full Text] [Related]
36. Acute renal effects of angiotensin converting enzyme inhibition in microalbuminuric type 1 diabetic patients.
Hansen KW; Pedersen MM; Christiansen JS; Mogensen CE
Acta Diabetol; 1993; 30(3):149-53. PubMed ID: 8111075
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
Hoogenberg K; Navis G; Dullaart RP
Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
[TBL] [Abstract][Full Text] [Related]
38. Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria.
Slomowitz LA; Bergamo R; Grosvenor M; Kopple JD
Am J Nephrol; 1990; 10(6):457-62. PubMed ID: 2075903
[TBL] [Abstract][Full Text] [Related]
39. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
[TBL] [Abstract][Full Text] [Related]
40. [Diabetic nephropathy and arterial hypertension: the physiopathological aspects and antihypertensive treatment].
Savazzi GM; Castiglioni A
Ann Ital Med Int; 1992; 7(3):160-4. PubMed ID: 1457255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
